|
Melatonin inhibits nitric oxide production by microvascular endothelial cells in vivo and in vitro
|
27 February 2020 |
|
The growth hormone receptor antagonist pegvisomant blocks both mammary gland development and MCF-7 breast cancer xenograft growth
|
22 February 2020 |
|
Inhibition of estrogen-independent mammary carcinogenesis by disruption of growth hormone signaling
|
19 February 2020 |
|
Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone
|
19 February 2020 |
|
Does growth hormone drive breast and other cancers?
|
19 February 2020 |
|
Advanced rat mammary cancers are growth hormone dependent
|
19 February 2020 |
|
New treatment approaches for prostate cancer based on peptide analogues
|
17 February 2020 |
|
Editorial comment on: new treatment approaches for prostate cancer based on peptide analogues (Bamias A and Dimopoulos MA)
|
17 February 2020 |
|
Editorial comment on: new treatment approaches for prostate cancer based on peptide analogues (McLeod)
|
17 February 2020 |
|
Induction of cell cycle arrest and apoptosis by a combined treatment with 13-cis-retinoic acid, interferon-alpha2a, and alpha-tocopherol in squamous cell carcinoma of the head and neck
|
13 February 2020 |